PierianDx, a provider of clinical genomic analysis, interpretation and reporting has acquired Provo, UT-based Tute Genomics. For PierianDx, the acquisition of Tute Genomics’ leading constitutional and exome testing capabilities will provide a single clinical platform for best in class clinical workflow support of somatic cancer and constitutional testing. Financial details of the acquisition were not disclosed.The transaction includes incorporating Tute leadership, advisors and developers into
Read More
- Skip to main content
- Skip to secondary menu
- Skip to primary sidebar
- Skip to secondary sidebar
- Skip to footer
Footer
